Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Mok

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
Human Molecular Genetics|February 26, 2014
Analysis of non-synonymous-coding variants of Parkinson's disease-related pathogenic and susceptibility genes in East Asian populationsJia Nee Foo, Louis C Tan, Herty Liany, et al.
JAMA Neurology|August 15, 2022
Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A ReviewHugh S Markus, Wiesje M van Der Flier, Eric E Smith, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer diseaseLarry Baum, Christopher Wai Kei Lam, Stanley Kwok-Kuen Cheung, et al.
The Lancet. Neurology|July 23, 2013
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationJoanna M Wardlaw, Eric E Smith, Geert J Biessels, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 11, 2020
UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: Questionnaire and workshop proceedingsAisling McFall, Tuuli M Hietamies, Ashton Bernard, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 13, 2016
Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel diseaseFrançois De Guio, Eric Jouvent, Geert Jan Biessels, et al.
Neurobiology of Aging|November 6, 2016
Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter studyLisa Wang, Michael G Heckman, Jan O Aasly, et al.
Neurobiology of Aging|November 27, 2024
Cerebral white matter hyperintensity volumes: Normative age- and sex-specific values from 15 population-based cohorts comprising 14,876 individualsFloor A S de Kort, Elisabeth J Vinke, Ewoud J van der Lelij, et al.
Stroke|August 20, 2025
Signature White Matter Hyperintensity Locations Associated With Vascular Risk Factors Derived From 15 653 IndividualsJ Matthijs Biesbroek, Floor A S de Kort, Devasuda Anblagan, et al.
Human Molecular Genetics|December 25, 2016
Genome-wide association study of Parkinson's disease in East AsiansJia Nee Foo, Louis C Tan, Ishak D Irwan, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Human Molecular Genetics|February 26, 2014
Analysis of non-synonymous-coding variants of Parkinson's disease-related pathogenic and susceptibility genes in East Asian populationsJia Nee Foo, Louis C Tan, Herty Liany, et al.
JAMA Neurology|August 15, 2022
Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A ReviewHugh S Markus, Wiesje M van Der Flier, Eric E Smith, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer diseaseLarry Baum, Christopher Wai Kei Lam, Stanley Kwok-Kuen Cheung, et al.
The Lancet. Neurology|July 23, 2013
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationJoanna M Wardlaw, Eric E Smith, Geert J Biessels, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 11, 2020
UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: Questionnaire and workshop proceedingsAisling McFall, Tuuli M Hietamies, Ashton Bernard, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 13, 2016
Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel diseaseFrançois De Guio, Eric Jouvent, Geert Jan Biessels, et al.
Neurobiology of Aging|November 6, 2016
Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter studyLisa Wang, Michael G Heckman, Jan O Aasly, et al.
Neurobiology of Aging|November 27, 2024
Cerebral white matter hyperintensity volumes: Normative age- and sex-specific values from 15 population-based cohorts comprising 14,876 individualsFloor A S de Kort, Elisabeth J Vinke, Ewoud J van der Lelij, et al.
Stroke|August 20, 2025
Signature White Matter Hyperintensity Locations Associated With Vascular Risk Factors Derived From 15 653 IndividualsJ Matthijs Biesbroek, Floor A S de Kort, Devasuda Anblagan, et al.
Human Molecular Genetics|December 25, 2016
Genome-wide association study of Parkinson's disease in East AsiansJia Nee Foo, Louis C Tan, Ishak D Irwan, et al.
Pageof 20